Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Toxicological Findings of Synthetic Cannabinoids in Recreational Users
Robert Kronstrand, Mabel Jouve, Mikael Andersson, et al.
Journal of Analytical Toxicology (2013) Vol. 37, Iss. 8, pp. 534-541
Open Access | Times Cited: 126

Showing 1-25 of 126 citing articles:

Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications
Marisol S. Castaneto, David A. Gorelick, Nathalie A. Desrosiers, et al.
Drug and Alcohol Dependence (2014) Vol. 144, pp. 12-41
Open Access | Times Cited: 657
A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment
Robert J. Tait, David Caldicott, David Mountain, et al.
Clinical Toxicology (2015) Vol. 54, Iss. 1, pp. 1-13
Open Access | Times Cited: 354
Novel psychoactive substances of interest for psychiatry
Fabrizio Schifano, Laura Orsolini, Gabriele Duccio Papanti, et al.
World Psychiatry (2015) Vol. 14, Iss. 1, pp. 15-26
Open Access | Times Cited: 303
Four Postmortem Case Reports with Quantitative Detection of the Synthetic Cannabinoid, 5F-PB-22
George Behonick, Kevin G. Shanks, Dennis Firchau, et al.
Journal of Analytical Toxicology (2014) Vol. 38, Iss. 8, pp. 559-562
Open Access | Times Cited: 163
Synthetic Cannabinoids—Further Evidence Supporting the Relationship Between Cannabinoids and Psychosis
Liana Fattore
Biological Psychiatry (2016) Vol. 79, Iss. 7, pp. 539-548
Closed Access | Times Cited: 147
Baths Salts, Spice, and Related Designer Drugs: The Science Behind the Headlines
Michael H. Baumann, Ernesto Solis, Lucas R. Watterson, et al.
Journal of Neuroscience (2014) Vol. 34, Iss. 46, pp. 15150-15158
Open Access | Times Cited: 145
Synthetic cannabinoid drug use as a cause or contributory cause of death
Laura M. Labay, James L. Caruso, Thomas Gilson, et al.
Forensic Science International (2016) Vol. 260, pp. 31-39
Closed Access | Times Cited: 142
Synthetic cannabinoids pharmacokinetics and detection methods in biological matrices
Marisol S. Castaneto, Ariane Wohlfarth, Nathalie A. Desrosiers, et al.
Drug Metabolism Reviews (2015) Vol. 47, Iss. 2, pp. 124-174
Closed Access | Times Cited: 108
Death after use of the synthetic cannabinoid 5F-AMB
Kevin G. Shanks, George Behonick
Forensic Science International (2016) Vol. 262, pp. e21-e24
Closed Access | Times Cited: 104
Post-Mortem Toxicology: A Systematic Review of Death Cases Involving Synthetic Cannabinoid Receptor Agonists
Arianna Giorgetti, Francesco Paolo Busardò, Roberta Tittarelli, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 103
Fatal intoxication with synthetic cannabinoid MDMB-CHMICA
Piotr Adamowicz
Forensic Science International (2016) Vol. 261, pp. e5-e10
Closed Access | Times Cited: 91
LC-QTOF-MS as a superior strategy to immunoassay for the comprehensive analysis of synthetic cannabinoids in urine
Robert Kronstrand, Linda Brinkhagen, Carolina Birath-Karlsson, et al.
Analytical and Bioanalytical Chemistry (2014) Vol. 406, Iss. 15, pp. 3599-3609
Closed Access | Times Cited: 90
Synthetic cannabinoid use in a nationally representative sample of US high school seniors
Joseph J. Palamar, Patricia Acosta
Drug and Alcohol Dependence (2015) Vol. 149, pp. 194-202
Open Access | Times Cited: 86
Toxicology and Management of Novel Psychoactive Drugs
Brian Kersten, Megan McLaughlin
Journal of Pharmacy Practice (2014) Vol. 28, Iss. 1, pp. 50-65
Closed Access | Times Cited: 81
Fatal Intoxications Associated with the Designer Opioid AH-7921
Robert Kronstrand, Gunilla Thelander, Daniel Lindstedt, et al.
Journal of Analytical Toxicology (2014) Vol. 38, Iss. 8, pp. 599-604
Open Access | Times Cited: 79
An Outbreak of Exposure to a Novel Synthetic Cannabinoid
Andrew A. Monte, Alvin C. Bronstein, Dazhe Cao, et al.
New England Journal of Medicine (2014) Vol. 370, Iss. 4, pp. 389-390
Open Access | Times Cited: 78
Characteristics and circumstances of synthetic cannabinoid-related death
Shane Darke, Johan Duflou, Michael Farrell, et al.
Clinical Toxicology (2019) Vol. 58, Iss. 5, pp. 368-374
Closed Access | Times Cited: 75
Acute Effects of Synthetic Cannabinoids: Update 2015
Juliana Tournebize, Valérie Gibaja, Jean‐Pierre Kahn
Substance Abuse (2016) Vol. 38, Iss. 3, pp. 344-366
Closed Access | Times Cited: 74
Synthetic cannabinoids: the hidden side of Spice drugs
Nicholas Pintori, Barbara Loi, Maddalena Mereu
Behavioural Pharmacology (2017) Vol. 28, Iss. 6, pp. 409-419
Closed Access | Times Cited: 74
Cannabis: An Overview of its Adverse Acute and Chronic Effects and its Implications
Talitha C. Ford, Amie C. Hayley, Luke A. Downey, et al.
Current Drug Abuse Reviews (2017) Vol. 10, Iss. 1, pp. 6-18
Open Access | Times Cited: 66
The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations
Noreen Dadirai Mdege, Nick Meader, Charlie Lloyd, et al.
Public Health Research (2017) Vol. 5, Iss. 4, pp. 1-138
Open Access | Times Cited: 65
Characteristics associated with synthetic cannabinoid use among patients treated in a public psychiatric emergency setting
Adriana M. Joseph, Marc W. Manseau, Monique Lalane, et al.
The American Journal of Drug and Alcohol Abuse (2016) Vol. 43, Iss. 1, pp. 117-122
Closed Access | Times Cited: 62
New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature
Stefania Chiappini, Alessio Mosca, Andrea Miuli, et al.
Medicina (2021) Vol. 57, Iss. 6, pp. 580-580
Open Access | Times Cited: 47
Electrooxidation of New Synthetic Cannabinoids: Voltammetric Determination of Drugs in Seized Street Samples and Artificial Saliva
Marina Dronova, Evgeny Smolianitski, Ovadia Lev
Analytical Chemistry (2016) Vol. 88, Iss. 8, pp. 4487-4494
Closed Access | Times Cited: 58
Case reports of synthetic cannabinoid XLR-11 associated fatalities
Kevin G. Shanks, David Winston, John Heidingsfelder, et al.
Forensic Science International (2015) Vol. 252, pp. e6-e9
Closed Access | Times Cited: 55
Page 1 - Next Page

Scroll to top